Company Sun Biopharma Inc OTC Bulletin Board

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Software

Inactive Instrument

Sun BioPharma, Inc., formerly Cimarron Medical, Inc., is a clinical stage drug development company. The Company is a biopharmaceutical company focused on developing therapies for pancreatic diseases. It is engaged in the commercial development of a polyamine analogue for pancreatic cancer and for a second indication in chronic pancreatitis. The Company's products include SBP-101, SBP-102 and SBP-103. Its SBP-101 is a polyamine compound and exhibits specificity for the exocrine pancreas, with therapeutic potential for both pancreatic cancer and pancreatitis indications. It develops SBP-101 for the treatment of patients with pancreatic ductal adenocarcinoma. The SBP-102 product is in non-clinical feasibility evaluation for the treatment of patients with pancreatitis. The SBP-103 product is in non-clinical exploratory evaluation. The Company has enrolled first patient in its Phase I clinical trial of SBP-101 in patients with previously treated pancreatic cancer.

Managers	Title	Age	Since
Michael Cullen FOU	Founder	78	11-09-20
Jennifer Simpson CEO	Chief Executive Officer	55	20-07-15
Susan Horvath DFI	Director of Finance/CFO	65	18-04-16
Tammy Groene COO	Chief Operating Officer	-	12-03-31
Elizabeth Bruckheimer CTO	Chief Tech/Sci/R&D Officer	-	22-05-31
Rachel Bragg PRN	Corporate Officer/Principal	-	21-05-31
James Carbonara		-	-

Members of the board	Title	Age	Since
Jennifer Simpson CEO	Chief Executive Officer	55	20-07-15
Jeffrey Mathiesen BRD	Director/Board Member	63	15-09-29
Michael Cullen FOU	Founder	78	11-09-20
Jeffrey Jacob BRD	Director/Board Member	62	22-06-14
Arthur Fratamico BRD	Director/Board Member	58	19-12-15
Dan Donovan BRD	Director/Board Member	59	22-06-14
Donald Schemel BRD	Director/Board Member	68	15-09-03

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	4,854,882	4,854,791 ( 100.00 %)	21 ( 0.000432 %)	100.00 %

Name	Equities	%	Valuation
HRT Financial LLC 0.0393 %	1,907	0.0393 %	1 278 $
Citadel Securities GP LLC 0.0352 %	1,711	0.0352 %	1 146 $
Goldman Sachs & Co. LLC 0.0253 %	1,226	0.0253 %	821 $
Geode Capital Management LLC 0.0164 %	794	0.0164 %	532 $
Tower Research Capital LLC 0.0155 %	751	0.0155 %	503 $
J.P. Morgan SE 0.0128 %	623	0.0128 %	417 $
Two Sigma Securities LLC 0.0120 %	584	0.0120 %	391 $
Donald Schemel 0.000453 %	22	0.000453 %	15 $
Michael Cullen 0.000453 %	22	0.000453 %	15 $
Dan Donovan 0.000227 %	11	0.000227 %	7 $

Panbela Therapeutics, Inc.

712 Vista Boulevard Suite 305

55387, Waconia

+952 479 1196

http://www.panbela.com

Technology

Software & IT Services

Software & IT Services

Other Software

	1st Jan change	Capi.
MICROSOFT CORPORATION	+3.53%	2,990B
SYNOPSYS INC.	+3.05%	83.1B
CADENCE DESIGN SYSTEMS, INC.	+1.20%	76.88B
DASSAULT SYSTÈMES SE	-16.29%	52.88B
PALANTIR TECHNOLOGIES INC.	+27.96%	50.84B
ATLASSIAN CORPORATION	-27.56%	46.09B
THE TRADE DESK, INC.	+15.13%	41.3B
SEA LIMITED	+56.02%	37.06B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	-11.27%	24.61B

Other Software